Novartis CEO Vas Narasimhan Joins Anthropic Board Amidst AI-Pharma Convergence
Trendline

Novartis CEO Vas Narasimhan Joins Anthropic Board Amidst AI-Pharma Convergence

What's Happening? Vas Narasimhan, the CEO of Novartis, has joined the board of directors for Anthropic, an artificial intelligence company, in April 2026. This move highlights a growing trend of convergence between the pharmaceutical industry and AI technology. Pharmaceutical giants like Novartis an
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.